Back to GALE Stock Lookup

Galena Biopharma (GALE) – Press Releases

Nov 30, 2016 01:31 PM Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium
Nov 14, 2016 07:05 AM Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016
Nov 9, 2016 04:10 PM Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update
Nov 3, 2016 07:05 AM Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer
Oct 31, 2016 04:30 PM Galena Biopharma Announces Reverse Stock Split
Oct 26, 2016 07:05 AM Galena Biopharma to Report Third Quarter 2016 Financial Results and Provide a Corporate Update on Wednesday, November 9, 2016
Oct 20, 2016 07:05 AM Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016
Oct 10, 2016 07:05 AM Galena Biopharma to Present NeuVax™ (nelipepimut-S) plus Trastuzumab Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress
Sep 29, 2016 07:05 AM Galena Biopharma to Present NeuVax™ (nelipepimut-S) Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress
Sep 27, 2016 04:05 PM Galena Biopharma Presents GALE-301 Folate Binding Protein Expression Data at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Sep 20, 2016 07:05 AM Galena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum
Sep 14, 2016 07:05 AM Galena Biopharma to Present at the 2016 Aegis Growth Conference
Sep 13, 2016 09:50 AM Galena Biopharma Presents Preclinical NeuVax™ (nelipepimut-S) Data in Ovarian and Pancreatic Cancer at the Progress in Vaccination Against Cancer (PIVAC) Conference
Sep 12, 2016 07:05 AM Galena Biopharma Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan
Sep 9, 2016 07:05 AM Galena Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Aug 9, 2016 04:05 PM Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update
Jul 26, 2016 07:05 AM Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, August 9, 2016
Jul 13, 2016 04:35 PM Galena Biopharma Announces Closing of Registered Direct Offering
Jul 8, 2016 07:35 AM Galena Biopharma to Host Webcast and Conference Call Today
Jul 8, 2016 07:05 AM Galena Biopharma Announces Pricing of Registered Direct Offering
Jun 29, 2016 07:05 AM Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation
Jun 13, 2016 07:05 AM Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress
Jun 10, 2016 02:47 PM Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Jun 6, 2016 02:00 PM Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016
Jun 1, 2016 07:05 AM Galena Biopharma Receives Fast Track Designation for NeuVax™ (nelipepimut-S) PRESENT Clinical Trial
May 24, 2016 07:05 AM Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncology BD&L and Investment Forum
May 19, 2016 12:15 PM Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hematology Association 21st Congress
May 18, 2016 05:45 PM Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016
May 10, 2016 04:10 PM Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update
Apr 27, 2016 07:05 AM Galena Biopharma to Report First Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, May 10, 2016
Apr 26, 2016 07:05 AM Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors
Apr 19, 2016 09:05 AM Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting
Mar 29, 2016 07:05 AM Galena Biopharma Phase 3 PRESENT Clinical Trial with NeuVax™ (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event
Mar 11, 2016 01:57 PM Galena Biopharma Corrects Error in Form 10-K
Mar 10, 2016 04:10 PM Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update
Mar 7, 2016 07:05 AM Galena Biopharma to Present at the 28th Annual ROTH Conference
Feb 26, 2016 07:05 AM Galena Biopharma to Report Fourth Quarter and Year End 2015 Financial Results and Provide a Corporate Update on Thursday, March 10, 2016
Feb 8, 2016 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)
Feb 2, 2016 07:05 AM Galena Biopharma to Present at the BIO CEO & Investor Conference
Jan 21, 2016 04:10 PM Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients at the ASCO 2016 Gastrointestinal Cancers Symposium
Jan 13, 2016 07:05 AM Galena Biopharma Provides 2016 Outlook
Jan 11, 2016 07:05 AM Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference
Jan 7, 2016 09:25 AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
Jan 6, 2016 04:26 PM Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
Dec 30, 2015 02:00 AM Midatech Completes Acquisition of Zuplenz®
Dec 24, 2015 07:05 AM Galena Biopharma Announces a Change to Its Board of Directors
Dec 18, 2015 07:05 AM Galena Biopharma to Sell Zuplenz® (ondansetron) Oral Soluble Film, Completing Divestiture of Commercial Operations
Dec 18, 2015 02:00 AM Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma, Inc.
Dec 11, 2015 07:05 AM Galena Biopharma Announces Departure of Chief Financial Officer
Dec 8, 2015 07:05 AM Galena Biopharma Presents Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition

Back to GALE Stock Lookup